Objective: To compare the pharmacokinetic profile and bioavailability of budesonide after inhalation from the Clickhaler® dry powder inhaler with the Turbuhaler® as standard. Design: Randomised, ...
April 5, 2005 — The European Commission has approved for use in the European Union a second-generation embolic protection system for use in saphenous vein graft interventional procedures; the Japanese ...
U.K.-owned Vectura Group said today it formed a RMB 400 million ($65 million) joint venture with two Chinese partners aimed at commercializing new respiratory products in China and the rest of Asia.
Recipharm AB has announced that it is working with Vectura Group plc to provide access to its license for the regulatory dossier of Asmasal® for the Chinese regulatory authorities as part of the ...
Chippenham, UK – 13 May 2013:Vectura Group plc (LSE: VEC) ("Vectura"), announces that it has established Tianjin Kinnovata Pharmaceutical Company Limited ("Kinnovata") in China with two partners; ...
Merck KGaA of Germany has set up a dedicated business to tap into the fast-growing market for respiratory drugs. Part of Merck Generics, the unit will focus on developing new respiratory drugs for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results